A phase II trial of niraparib plus dostarlimab in relapsed small cell lung cancer and other high-grade neuroendocrine carcinomas

被引：5
|
作者：
Gay, Carl M.
Stewart, C. Allison
Frumovitz, Michael
Fujimoto, Junya
Xi, Yuann
Wang, Qi
Wang, Runsheng
Novegil, Veronica
Altan, Mehmet
Cascone, Tina
Dasari, Arvind
Elamin, Yasir Y.
Fossella, Frank V.
Glisson, Bonnie S.
Lu, Charles S.
Negrao, Marcelo V.
Skoulidis, Ferdinandos
Vokes, Natalie
Cardnell, Robert J.
Wistuba, Ignacio I.
Wang, Jing
Heymach, John V.
Byers, Lauren A.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT218
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer
    Johnson, E
    Lake, D
    Herndon, JE
    Box, JW
    Lynch, TJ
    Green, MR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01): : 19 - 23
  • [2] High-grade extrapulmonary neuroendocrine carcinomas and small cell lung cancer: Different entities, same treatment.
    De Mendonga Rego, Juliana Florinda
    Medeiros, Raphael Salles S.
    Freitas Melro Braghiroli, Maria Ignez
    Galvao, Breno
    Bezerra Neto, Joao Evangelista
    Munhoz, Rodrigo Ramella
    Guerra, Juliana Mariotti
    Kimura, Lidia
    Nonogaki, Suely
    Flesch Pfiffer, Tulio Eduardo
    Castro, Gilberto
    Hoff, Paulo Marcelo
    Rocha Filho, Duilio
    Costa, Frederico
    Riechelmann, Rachel Pimenta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Phase II Trial of Vinflunine in Relapsed Small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Lane, Cassie M.
    Clark, Bobby
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 874 - 878
  • [4] A phase II trial of bellotecan in relapsed small cell lung cancer
    Kim, Y. -C.
    Kim, K. -S.
    Kim, S. -Y.
    Jeong, E. -T.
    Jung, M. -H.
    Lee, K. -H.
    Lee, J. C.
    Ryu, J. -S.
    Park, K. -O.
    Back, S. -M.
    Kim, M. -R.
    Na, K. -J.
    Kim, Y. -H.
    Ahn, S. -J.
    LUNG CANCER, 2006, 52 : S24 - S24
  • [5] Behaviour and survival of high-grade neuroendocrine carcinomas of the lung
    Naranjo Gomez, J. M.
    Gomez Roman, J. J.
    RESPIRATORY MEDICINE, 2010, 104 (12) : 1929 - 1936
  • [6] Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial
    Passiglia, Francesco
    Righi, Luisella
    Bironzo, Paolo
    Listi, Angela
    Farinea, Giovanni
    Capelletto, Enrica
    Novello, Silvia
    Merlini, Alessandra
    Scagliotti, Giorgio V.
    CLINICAL CANCER RESEARCH, 2024, 30 (05) : 959 - 964
  • [7] Phase II trial of vinflunine in patients with relapsed small cell lung cancer
    Peyton, J. D.
    Spigel, D. R.
    Hainsworth, J. D.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E.
    Farley, C.
    Porter, L.
    Lunin, S.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] CAN: A Phase II Trial of Combination of Niraparib and Anlotinib in Patients with Recurrent Small Cell Lung Cancer
    Cheng, Y.
    Liu, Y.
    Xin, Y.
    Zhu, J.
    Cui, H.
    Zhang, L.
    Wang, Y.
    Zhang, Q.
    Wei, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S379 - S379
  • [9] CAN: A Phase II Trial of Combination of Niraparib and Anlotinib in Patients with Recurrent Small Cell Lung Cancer
    Cheng, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S530 - S530
  • [10] Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer
    Fennell, Dean A.
    Steele, Jeremy P. C.
    Shamash, Jonathan
    Slater, Sarah E.
    Sheaff, Michael T.
    Wells, Paula
    Rudd, Robin M.
    Stebbing, Justin
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (11) : 2575 - 2577
12345